Part III of this review describes the impact that acupuncture, our drug culture, and the gate-control theory have had on our progress in elucidating pain mechanisms and in treating pain syndromes. Whether an analgesia is produced by morphine, acupuncture, or electrical stimulation of an appropriate brain region, the analgesia can be blocked by naloxone, a morphine antagonist. This observation, among others, suggests that similar effector mechanisms involving endogenous opiates serve all three types of analgesia. Although the gate-control theory must continually be revised to accord with new information, it has been a major impetus for stimulating fruitful research. 
; others sang its praises 277, 278 ; and others began the arduous task of acquiring new knowledge concerning this ancient practice. 275, [279] [280] [281] [282] [283] [284] [285] [286] [287] [288] [289] Hence, Western medicine is greatly indebted to the Chinese for introducing us to this ancient practice of acupuncture, not because it has become an important tool in modern medicine (its popularity has rapidly waned since its introduction), but because it raised questions whose answers were to be derived by applying the experimental scientific approach.
As a result of cooperation among biochemists, pharmacologists, histologists, electrophysiologists, and other neuroscientists from multiple disciplines working together toward a common goal, "the veil of obscurity is slowly being raised." 290 The explanation for the mechanisms of acupunc ture is that an acupuncturist produces analgesia by twirling acupuncture needles in appropriate body regions or sending currents through these needles.
for pain in the ventral central gray matter, with the ultimate release of endogenous opiates.
DRUG ADDICTION
The use of morphine in treating chronic pain leads to tolerance and addiction. That is, a morphinetreated patient soon requires larger injections. He becomes dependent upon morphine and suffers severe physiological consequences when the drug is discon tinued or when, for other reasons, he is deprived of morphine. The phenomena of tolerance and addic tion, although the heart of the "drug" problem in society today, are poorly understood. 294 From inves tigations designed to elucidate the mechanisms of drug analgesia, our current knowledge evolved about the structure, distribution, and function of the opiate receptors and the putative neural transmitters with which they interact (see Part II).
An early important result of these investigations was that the injection of morphine into the periaq ueductal gray matter produces analgesia.
176-183 This region of the brain was also shown to possess the highest density of opiate receptors.
184-188 Was this, then, giving rise to central inhibition of pain?
STIMULUS-PRODUCED ANALGESIA (SPA)
About the same time that acupuncture and opiate receptors were being analyzed, it was shown that electrical stimulation of the periventricular and peri aqueductal gray matter also gave rise to long-lasting analgesia.
295-298 Other brain structures were also iden tified that, when electrically stimulated, produced analgesia. 299 Among these regions were the septal area, 300 314 and the midbrain. 315 This stimulus-produced analgesia (SPA) is specific for reducing pain; it does not interfere with motor function or gross behavioral responses. The analgesia produced by electrical stim ulation of the periaqueductal gray matter has been reported to be sufficient to permit abdominal surgery without anesthetics. 316 Because SPA promises a revolutionary means for relieving pain, it has attracted the attention of many investigators. As a result, many scattered observations have been reported. Examples of these follow.
The periaqueductal area is not composed of a homogeneous population of neurons. Stimulation of the medial caudal zone of the periaqueductal gray matter produces analgesia, whereas stimulation of the rostral and lateral zones activates nociceptive sensa tions. 35 Naloxone, a morphine antagonist that blocks opi ate receptors, also interferes with the analgesia evoked by electrical stimulation. 317 This observation suggests that botn electrical stimulation of the periaqueductal gray matter and acupuncture may involve common effector mechanisms because naloxone blocks the analgesia produced by either. Another recent obser vation is that SPA has a powerful inhibitory effect on nociceptive neurons in lamina V of the dorsal horn 295, 309, 315 and on neurons of the nucleus gigantocellularis in the medulla but not on the nonnociceptive neurons in the same regions.
175, 295, 306, 307
Other experiments have shown that transection of the dorsolateral quadrant of the spinal cord abolishes SPA on the side of the lesion. This quadrant of the cord contains serotonin-containing fibers descending from the raphe magnus nuclei of the medulla.
318, 319
The full explanation of all of these findings awaits further study. One explanation at this time is that SPA is mediated by serotonergic neurons whose de scending fibers terminate in axo-axonic synapses on the small primary afferent terminals in the dorsal horns, as shown by the hypothetical scheme in Figure  12 . Electrical stimulation in the periaqueductal gray matter is thought to cause the release of enkephalin from nearby enkephalinergic nerve terminals or interneurons. The enkephalin, in turn, activates sero tonergic neurons by interacting with opiate receptors found in abundance on these neurons. Morphine injected into this same brain region is thought to imitate the action of the endogenous enkephalin re leased by electrical stimulation.
Although the scheme in Figure 12 could explain some aspects of SPA, it fails to account for the very long-lasting analgesia produced by electrical stimu lation of the periaqueductal gray matter. Results of a recent study suggest an additional mode of SPA action. 320 This study showed that the long-lasting analgesia produced by stimulation of the periaque ductal gray matter in patients with pain of peripheral origin was accompanied by an increase in the β-endorphin concentration in ventricular cerebrospinal fluid. Naloxone abolished the SPA. The authors pro posed that the electrical stimulation of the periaque ductal gray matter might induce antidromic stimula tion of the anterior hypothalamic β-endorphin fibers and the subsequent release of β-endorphin into the third ventricle.
Naloxone is thought to block the opiate receptors on serotonergic neurons in the brain as well as those on the terminals of the primary afferent fibers in the dorsal horns because it blocks analgesia whether pro duced by electrical stimulation of the periaqueductal Volume 60 / Number 1, January 1980 gray matter, by injection of morphine into the peri aqueductal gray matter, or by acupuncture.
TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION
As physical therapists well know, electrical stimu lation in the periphery may also produce analgesia. This technique is called transcutaneous electrical nerve stimulation, or TENS. The reader is directed to the special issue of PHYSICAL THERAPY on TENS, published in December 1978, for details concerning this potentially effective means for managing acute or chronic pain. It is interesting that this clinical tech nique was a direct result of a contemporary theory about the neural mechanisms of pain. A very brief statement of that theory follows.
GATE-CONTROL THEORY
Until the early 1960s most theories about cutaneous sensation assumed that impulses arriving at the cord over primary afferent fibers would be transmitted pretty much undistorted along ascending relay paths to the primary receiving areas of the cortex. Even though Matthews and co-workers discovered in the early 1930s that sensory input traveling through largediameter afferent fibers depolarized the central ter minals of other dorsal root fibers, 321 this phenomenon ("primary afferent depolarization" or "the dorsal root reflex") was pretty much ignored for 20 years. In the late 1950s the phenomenon was again investigated.
202-

219
This time its importance was recognized and it was incorporated into a theory of the neural mechanisms underlying pain. This theory, published by Melzack and Wall in 1965, was called the "gate-control theory of pain." 322 The theory stated that transmission of sensation is controlled by the balance of activity in small-diameter, slow-conducting fibers and large-di ameter, fast-conducting fibers entering the spinal cord. According to the gate-control theory, low-level activity in the small fibers that carry impulses from the nociceptors is normally blocked at the first syn apse by activity in large primary fibers and by activity in fibers descending from higher brain regions. The "gate" at the first synapse is opened by intense activity in small fibers, as would occur with intense, painful stimulation during tissue damage. A predominance of activity in large fibers closes the "gate"; a predom inance of activity in small fibers opens the "gate." Hence, the "gate" through which pain signals are transmitted to the transmitter (or T) cells is variable.
Impulses descending from higher brain areas were also postulated to participate in the control of the "gate," but these descending pathways were not shown in the diagram of the 1965 paper and, hence, were originally ignored by most readers.
From Parts I and II of this review, it should be obvious to the reader that the gate-control theory has had tremendous impact upon pain research and upon clinical practice. It still sparks debate, 323 Part III described how the analgesic effects of acupuncture, SPA, and TENS may share common effector mechanisms involving enkephalinergic neu rons. This idea prompted a search for new analogues of enkephalin in hopes of developing a substance that will resist enzymatic breakdown while having an in vivo potency equivalent to β-endorphin. Thus far, all synthesized enkephalin-like compounds have caused tolerance and addiction-the same disadvantages in herent in long-term use of morphine.
Both our progress in understanding the mecha nisms of pain and our application of this knowledge for managing pain are increasing at a remarkable pace. I hope that this pace will continue unabated and that the future will find us with new modalities and pharmacological tools for treating intractable pain syndromes.
Editor's note: A self-assessment quiz, written by the author, is published in this issue. 
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